Cabozantinib S-malate
-
Cabozantinib S-malate
structure -
-
CAS No:
1140909-48-3
-
Formula:
C28H24FN3O5.C4H6O5
-
Chemical Name:
Cabozantinib S-malate
-
Synonyms:
Butanedioic acid,2-hydroxy-,(2S)-,compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N′-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1);XL 184;Cabozantinib S-malate;Cometriq;(2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N′-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1);942407-59-2
- Categories:
-
CAS No:
Description
Off-White SolidChEBI: A malate salt that is the mono-(S)-malate salt of cabozantinib. A multi-tyrosine kinase inhibitor, used for the treatment of progressive, metastatic, medullary thyroid cancer.
Cabozantinib malate is a malate salt that is the mono-(S)-malate salt of cabozantinib. A multi-tyrosine kinase inhibitor, used for the treatment of progressive, metastatic, medullary thyroid cancer. It has a role as a tyrosine kinase inhibitor, an antineoplastic agent and a prodrug. It contains a cabozantinib.|Cabozantinib S-malate is the s-malate salt form of cabozantinib, an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Cabozantinib strongly binds to and inhibits several RTKs, which are often overexpressed in a variety of cancer cell types, including hepatocyte growth factor receptor (MET), RET (rearranged during transfection), vascular endothelial growth factor receptor types 1 (VEGFR-1), 2 (VEGFR-2), and 3 (VEGFR-3), mast/stem cell growth factor (KIT), FMS-like tyrosine kinase 3 (FLT-3), TIE-2 (TEK tyrosine kinase, endothelial), tropomyosin-related kinase B (TRKB) and AXL. This may result in an inhibition of both tumor growth and angiogenesis, and eventually lead to tumor regression.
Safety Information
|Danger|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P201, P202, P260, P261, P264, P270, P271, P280, P281, P301+P312, P302+P352, P304+P340, P305+P351+P338, P308+P313, P312, P314, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 51 companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Renal Cell Carcinoma (RCC)Cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (RCC):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (VEGF)-targeted therapy.Cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults.Hepatocellular Carcinoma (HCC)Cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (HCC) in adults who have previously been treated with sorafenib.|Drug: Cabozantinib-s-malate
BMS 907351
Cabozantinib S-malate Use and Manufacturing
Cabozantinib is a small molecule C-Met modulator. Cabozantinib acts as a potent multitargeted VEGFR2, Met, FLT3, Tie2, Kit and Ret inhibitor with IC50 of 0.035, 1.8, 14.4, 14.3 and 4.6 nM for VEGFR2, Met, FLT3, Tie2 and Kit, respectively. Cabozantinib shows dose-dependent inhibition of tumor growth and tumor regression, associated with disruption of the tumor vasculature and extensive tumor cell a poptosis. XL184 (Cabozantinib, BMS-907351) is a potent multitargeted VEGFR2, Met, FLT3, Tie2, K
Human drugs -> Cabometyx -> EMA Drug Category|Antineoplastic agents -> Human pharmacotherapeutic group|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:635.6
Hydrogen Bond Donor Count:5
Hydrogen Bond Acceptor Count:12
Rotatable Bond Count:11
Exact Mass:635.19152232
Monoisotopic Mass:635.19152232
Topological Polar Surface Area:194
Heavy Atom Count:46
Complexity:924
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Recommended Suppliers of Cabozantinib S-malate
-
![China]()
CN
YRS
Business licensed Certified factoryManufactory Supplier of Active Pharm Ingredients,Chemical Catalyst,Pharmaceutical Intermediates,Flavors and Fragrances,Agrochemicals,Chemical Pesticides,Organic Intermediates,OLED IntermediatesInquiryCAS No.: 1140909-48-3Grade: Pharmaceutical GradeContent: 99% -
![China]()
CN
YRS
Business licensed Certified factoryManufactory Supplier of prostaglandinsInquiryUnit Price: nullnull /null nullCAS No.: 1140909-48-3Grade: Pharmaceutical GradeContent: 98% -
![China]()
CN
YRS
Business licensedTrader Supplier of semaglutide,tirzepatide,Liraglutide,Retatrutide,5-amino-1MQ,SLU-PP-332,Bam-15,Spermidine HCL,ghk-cu,ss31,FOXO-4 DRIInquiryCAS No.: 1140909-48-3Grade: Top ProductContent: 99% -
![China]()
CN
YRS
Business licensedTrader Supplier of additives,pharmaceutical chemicals,organic intermediate,chemical intermediates,Pharmaceutical Intermediates,catalyst,APIInquiryUnit Price: nullnull /null nullCAS No.: 1140909-48-3Grade: Pharmaceutical gradeContent: 99% -
![United States]()
US
YRS
Business licensed Certified factoryManufactory Supplier of Coenzymes,Inhibito,Enzymes,Zymogens,SubstratesInquiryUnit Price: nullnull /null nullCAS No.: 1140909-48-3Grade: nullContent: null%
Learn More Other Chemicals
-
Cabozantinib
849217-68-1
-
Sodium phenylbutyrate
1716-12-7
-
Afatinib dimaleate
850140-73-7
-
Idelalisib Formula
870281-82-6
-
Lenvatinib mesylate Formula
857890-39-2
-
Silodosin Formula
160970-54-7
-
Teneligliptin Hydrobromide Structure
906093-29-6
-
3-[1-[3-(Dimethylamino)propyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione Structure
133052-90-1
-
What is 2-[4-[[[2-[3-Fluoro-4-(trifluoromethyl)phenyl]-4-methyl-5-thiazolyl]methyl]thio]-2-methylphenoxy]acetic acid
317318-84-6
-
What is Dacomitinib
1110813-31-4